OS
Clinical trials for OS explained in plain language.
Never miss a new study
Get alerted when new OS trials appear
Sign up with your email to follow new studies for OS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to cut relapse in rare lymphoma
Disease control ENROLLING_BY_INVITATIONThis study tests a combination of the immunotherapy drug tislelizumab, chemotherapy, and radiation for people with early-stage (I-II) NK/T-cell lymphoma, a rare blood cancer. The goal is to see if this approach improves how many patients respond and helps prevent the cancer from …
Matched conditions: OS
Sponsor: Eye & ENT Hospital of Fudan University • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New combo therapy targets rare sinus cancer in adults
Disease control ENROLLING_BY_INVITATIONThis study is testing a treatment plan for adults with a rare type of sinus cancer called rhabdomyosarcoma. The plan includes chemotherapy, radiation therapy, and surgery. The goal is to see if this approach can shrink tumors and help people live longer. About 43 people will take…
Matched conditions: OS
Sponsor: Eye & ENT Hospital of Fudan University • Aim: Disease control
Last updated May 13, 2026 16:00 UTC